Silencing miR-181b-5p upregulates PIAS1 to repress oxidative stress and inflammatory response in rats with alcoholic fatty liver disease through inhibiting PRMT1-Reference-Cited by-同舟云学术

Silencing miR-181b-5p upregulates PIAS1 to repress oxidative stress and inflammatory response in rats with alcoholic fatty liver disease through inhibiting PRMT1

Published:2021-12 Issue: Volume:101 Page:108151
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Wang Wei,Zhong Guan-Zhen,Long Kai-Bing,Liu Yang,Liu Ya-Qian,Xu Ai-Lei^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference41 articles.

1. GanMeijian ameliorates lipid accumulation and oxidative damage in alcoholic fatty liver disease in Wistar rats;Li;Life Sci.,2020

2. Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency;Huang;Lab. Invest.,2020

3. Establishment of an alcoholic fatty liver disease model in mice;Tan;Am. J. Drug. Alcohol. Abuse,2017

4. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease;Laitakari;Redox Biol.,2019

5. Alcoholic and nonalcoholic fatty liver disease and liver-related mortality: a cohort study;Chang;Am. J. Gastroenterol.,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-378a-3p and miR-181b-5p as nonalcoholic steatohepatitis non-invasive diagnostic biomarkers and their correlations with liver fibrosis;The Ukrainian Biochemical Journal;2024-09-03

2. Metformin suppresses gastric cancer progression by disrupting the STAT1-PRMT1 axis;Biochemical Pharmacology;2024-08

3. The Regulatory Impact of CFLAR Methylation Modification on Liver Lipid Metabolism;International Journal of Molecular Sciences;2024-07-19

4. MicroRNA expression profile of chicken liver at different times after Histomonas meleagridis infection;Veterinary Parasitology;2024-07

5. Role of protein arginine methyltransferase 1 in obesity‐related metabolic disorders: Research progress and implications;Diabetes, Obesity and Metabolism;2024-05-15